Skip to main content
Normal View

Dáil Éireann debate -
Wednesday, 15 Nov 2000

Vol. 526 No. 1

Adjournment Debate. - Cancer Screening Programme.

I would like to raise an important question as to why half the female population has been excluded from the breast check programme. I raise this issue as a result of a question I tabled to the Minister for Health and Children on 24 October when I asked why there was no breast screening programme at Cork University Hospital. I was told by the Minister that his Department had received no submission from Cork University Hospital which, in ways, was a very misleading statement in that on checking the facts, I learned that the Minister had announced some time previously with glossy folders and brochures, the launch of the national breast screening programme.

When I heard of a national programme, I presumed it was truly national and that all parts of the country were being covered. It is obvious from the Minister's response that women who do not live within the Eastern Health Board, the North Eastern Health Board and Midland Health Board areas and who may be in the early stages of breast cancer, will not be screened. One of the leaflets I saw produced at the launch contained the question, "How do I get a breast screening appointment?". It did not give the answer, of course, that if one lives outside the Eastern Health Board, the North Eastern Health Board or the Midland Health Board areas, one simply does not get a check or an appointment. The next obvious question that came to me was that if one cannot get an appointment, when can one expect to get one if one happens to live in Donegal, Cork, Limerick or Galway? The answer is that nobody has a clue – it could be a short or long time depending on when areas outside those already mentioned are included in phase two or phase three.

On carefully inspecting the documentation relating to the national scheme, there is no definite commitment as to when phase two or phase three will be implemented. My concern is that it took ten years to progress the commencement of the pilot scheme in Eccles Street, the phase one. Will it be another ten years until we have phase two and a further ten years before we have phase three? Irish women and Deputies are entitled to a straight answer to a straight question.

On what basis was the decision taken to carry out screening in the Midland Health Board, the North Eastern Health Board and the Eastern Health Board areas and to exclude other major urban areas such as Cork, Limerick and Galway? The women to whom I have spoken would like to know the answer. I would like to know the reasons behind this discrimination and whether decisions are made on political rather than on medical grounds.

It has been claimed by the Minister, the Department and those operating the screening programme that a 20% reduction in mortality from breast cancer can be achieved by this programme. What does this mean? It means in the crudest terms, and if the figures are correct, that women with breast cancer outside the screening areas can expect to die in one fifth greater numbers than women inside the screening areas. Until such time as screening is finally extended to all the country, the so-called national screening programme is failing approximately half the women in this country by failing to offer them not merely screening, but even a firm timetable for screening.

If the organisers of breast check truly believe they can reduce deaths from breast cancer by 20%, then why are 20% of women with breast cancer outside the limits of certain health board areas being effectively condemned to death? Who is playing God in this case? At a time of plenty, the money for a proper national programme is surely there. National programmes should mean national and should not be piecemeal and callous. I would like to get some straight answers to the questions I put. I would also like to compliment Dr. Simon Mills of the Irish Medical Times for raising this important issue in that publication.

I thank Deputy Allen for raising this issue and I welcome the opportunity to clarify the position in relation to the programme. The planning process to initiate a national breast screening programme commenced in March 1997 when the then Minister for Health and Children, at the launch of the National Cancer Strategy Action Plan, established a steering group and quality assurance committee to oversee and develop an implementation plan for a national breast screening programme. One of the first decisions taken was that implementation should be on a phased basis.

Phase one of the National Breast Screening Programme will involve screening women aged 50 to 64 years in the Eastern, North Eastern and Midland Health Board areas. The target population is approximately 140,000 and represents approximately 50% of the total national target population. The decision to proceed on a phased basis is a reflection of the complexities involved in the screening process rather than the costs involved and the Department's key objective is to ensure that the programme meets the necessary quality assurance criteria.

The Minister is aware of the unnecessary trauma and anguish that could be caused to women and their families as a result of mistakes in an organised screening programme. For this reason the National Breast Screening Programme must be driven by international quality assurance standards and best practice. Specifically, the phasing will take account of the following critical success factors: the achievement of acceptable compliance levels among the target population; ongoing evaluation of the programme from a quality assurance perspective and availability of the necessary clinical expertise to conduct the programme.

At this stage, the screening age is limited to women between 50 and 64 years, but it is anticipated that, when the programme is sufficiently developed, consideration would be given to including older women and continuing screening of women already in the programme who have reached 65 years. Screening by mammography under the age of 50 remains unproven in terms of reduction in mortality.

The service is being delivered by two central units, the Eccles St. unit on the Mater Hospital campus and the Merrion unit on St. Vincent's Hospital campus, with outreach to the community by means of free mobile units. The Eccles unit commenced screening under the programme last February. Screening is also in progress in St. Vincent's Hospital and this will be expanded once construction of the new Merrion unit is complete. The first mobile unit commenced screening on 21 August 2000 in Longford.

Decisions in relation to subsequent phases of the programme will be guided by the experience gained from putting phase one of the programme in place. The steering committee has recommended that phase two of the programme should follow phase one as soon as is practicable.

I assure the Deputy that this is a national programme to which the Minister and I are fully committed and I am confident, from the experience thus far, that the objective of reducing mortality from breast cancer by 20% will be achieved and that early detection will lead to successful treatment for those women who present with the condition. Women are not excluded in other parts of the country. They can avail of other services available on the ground through their GP or by way of referral to out-patient clinics. The Deputy said it was ten years before phase 1 began. As the Minister has given a commitment, and as a good Corkman, I am sure he will have no problem getting phase 2 off the ground on record time. If this was a political decision, I am sure he would have begun in Cork, not in Dublin and the other regions. I agree with the Deputy that it would be nice to have a 20% reduction in cancers.

Top
Share